A patient with asthma presents with an FEV1 at 60% of predicted value and elevated FeNO levels despite regular use of inhaled corticosteroids. Which of the following should the nurse anticipate the healthcare provider might consider adding to the patient's treatment plan to address the ongoing symptoms?

B) Long-acting beta-agonist (LABA)

A) Short-acting beta-agonist (SABA) as needed

B) Long-acting beta-agonist (LABA)

Based on the diagnostic results and the identified issues in the management of the patient's asthma, which intervention should the nurse prioritize to address the patient's ongoing symptoms and inflammation?

C) Initiate a leukotriene receptor antagonist as an additional therapy.

A) Increase the dose of inhaled corticosteroids.

B) Educate the patient on proper inhaler technique and adherence.

C) Initiate a leukotriene receptor antagonist as an additional therapy.

D) Recommend complete avoidance of all potential allergens.

A patient with asthma presents with persistent symptoms despite adherence to her medication regimen, including a leukotriene receptor antagonist and a long-acting beta-agonist. Her eosinophil count is elevated, and she has a history of nasal polyps. Which of the following actions should the nurse anticipate as a priority in managing her care?

B) Assess for potential triggers such as aspirin use and refer to an allergist.

A) Educate the patient on proper inhaler technique and monitor peak flow readings.

B) Assess for potential triggers such as aspirin use and refer to an allergist.

C) Recommend an increase in dose of her current asthma medications.

D) Initiate oxygen therapy and prepare for potential hospitalization.

A patient with asthma reports persistent nighttime wheezing and shortness of breath despite adherence to a revised medication regimen. The healthcare team finds elevated eosinophil counts and serum IgE levels. Which of the following nursing interventions is most appropriate to address the suspected underlying issues?

B) Educate the patient on proper inhaler technique

A) Increase the dosage of the long-acting beta-agonist

B) Educate the patient on proper inhaler technique

C) Initiate high-dose corticosteroid therapy

D) Recommend complete avoidance of all potential allergens

A patient with asthma is experiencing worsening symptoms despite recent adjustments to her medication regimen and environmental controls. What is the most appropriate nursing action to address this issue based on the patient's case history?

D) Coordinate a follow-up appointment with the allergist to reassess her management plan.

A) Reinforce the use of proper inhaler technique and provide additional practice sessions.

B) Educate the patient on avoiding all forms of physical activity to prevent exacerbation.

C) Suggest the patient increase her inhaled corticosteroid dosage beyond the prescribed amount.

D) Coordinate a follow-up appointment with the allergist to reassess her management plan.

A patient with asthma is experiencing persistent symptoms despite adherence to her medication regimen, which includes inhaled corticosteroids and allergen immunotherapy. Upon assessment, she reports frequent exposure to a neighbor's cigarette smoke and the use of scented candles at home. What is the most appropriate nursing intervention to help improve her asthma control?

B) Educate the patient on avoiding environmental triggers

A) Increase the dosage of inhaled corticosteroids

B) Educate the patient on avoiding environmental triggers

C) Recommend using a nebulizer instead of an inhaler

D) Suggest regular use of over-the-counter antihistamines

A patient with asthma on allergen immunotherapy and an updated medication regimen reports increased shortness of breath and chest tightness. Her peak flow readings have decreased by 15% and spirometry shows a 20% reduction in FEV1. Which nursing intervention is most appropriate to address her current symptoms?

B) Instruct the patient to continue using her quick-relief inhaler as needed and monitor her symptoms.

A) Encourage the patient to increase her physical activity to improve lung function.

B) Instruct the patient to continue using her quick-relief inhaler as needed and monitor her symptoms.

C) Recommend discontinuation of the allergen immunotherapy due to its ineffectiveness.

D) Advise the patient to double her current dose of inhaled corticosteroids without consulting her healthcare provider.

A patient with asthma is experiencing increased shortness of breath and chest tightness despite adherence to her treatment plan. Her peak flow readings have decreased by 15% and spirometry indicates a 20% reduction in FEV1. The healthcare team has adjusted her treatment plan to include an increased dose of inhaled corticosteroids and a leukotriene receptor antagonist. What additional nursing intervention is most appropriate to support this patient’s asthma management?

A) Encourage the patient to keep a detailed symptom diary to identify potential triggers.

B) Advise the patient to use her rescue inhaler more frequently to prevent exacerbations.

C) Suggest that the patient discontinue physical activity until symptoms improve.

D) Recommend that the patient avoid all environmental allergens by staying indoors at all times.

A patient with asthma presents with symptoms of sinusitis, including facial pressure and headaches, which have been confirmed by a CT scan. The healthcare team has revised the treatment plan to include oral antibiotics. As a nurse, what is the most appropriate intervention to prioritize in the care of this patient?

A) Educate the patient on the importance of completing the full course of antibiotics.

B) Advise the patient to avoid all physical activity until symptoms improve.

C) Instruct the patient to increase fluid intake to thin mucus secretions.

D) Recommend the patient to use a humidifier only during nighttime.

A patient with asthma has been diagnosed with acute sinusitis, contributing to her respiratory discomfort. Which intervention should the nurse prioritize to address both her asthma and sinusitis symptoms effectively?

C) Educate the patient on the importance of adherence to the prescribed antibiotic course.

A) Encourage the patient to increase fluid intake to thin mucus secretions.

B) Advise the patient to use a nasal decongestant spray to relieve sinus pressure.

C) Educate the patient on the importance of adherence to the prescribed antibiotic course.

D) Recommend the use of a humidifier in the home to maintain airway moisture.

Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - In asthma, chronic inflammation causes swelling and narrowing of the airways, driven by immune cells like eosinophils and mast cells, leading to increased mucus production and heightened sensitivity to triggers.

• Secondary mechanism: Bronchoconstriction - Exposure to allergens or irritants triggers the contraction of smooth muscle around the airways, further narrowing the air passages and causing symptoms like wheezing and shortness of breath.

• Key complication: Airway remodeling - Over time, repeated inflammation and bronchoconstriction can lead to structural changes in the airway, such as thickening of the airway walls and increased mucus gland size, which can result in persistent airflow limitation and reduced response to treatment.

Patient Profile

Demographics:

32-year-old female, school teacher

History:

• Key past medical history: Diagnosed with asthma at age 15, history of seasonal allergies

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily

• Allergies: Penicillin, pollen

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, difficulty breathing at night, fatigue

• Vital signs: Blood pressure 138/88 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to conduct further diagnostic tests to better understand the patient's worsening symptoms and guide management. Pulmonary function tests (PFTs) were performed, revealing a reduced forced expiratory volume in one second (FEV1) at 60% of the predicted value, indicating a moderate obstruction in airflow. The FEV1/FVC ratio was also decreased, supporting the diagnosis of an obstructive pattern typical in asthma exacerbations. Fractional exhaled nitric oxide (FeNO) levels were elevated at 45 ppb, suggesting ongoing eosinophilic inflammation in the airways.

Additionally, a complete blood count (CBC) showed an elevated eosinophil count, further confirming the inflammatory response. Serum IgE levels were higher than normal, aligning with her history of allergic triggers. A chest X-ray ruled out any acute infection or pneumothorax but highlighted mild hyperinflation of the lungs, a common finding in asthma patients experiencing exacerbations.

These results suggest that the patient's asthma is not fully controlled and is complicated by a significant inflammatory component. The persistence of symptoms despite regular use of inhaled corticosteroids indicates that her current management plan may need adjustment. This new information opens avenues for clinical reasoning, prompting consideration of potential step-up therapy, such as the addition of a leukotriene receptor antagonist or a long-acting beta-agonist (LABA), and re-evaluation of trigger avoidance and adherence to her current regimen. The healthcare team must also consider the role of ongoing education about asthma management and monitoring for potential triggers, such as seasonal allergens, to prevent further complications.

Section 2

Change in Patient Status:

A week after the adjustment in her asthma management plan, the patient returned to the clinic for a follow-up evaluation. Despite the introduction of a leukotriene receptor antagonist and a long-acting beta-agonist to her regimen, she reported persistent wheezing and shortness of breath, particularly at night. Her peak flow readings at home showed variability, with values frequently falling below 70% of her personal best. This ongoing variability suggested that her asthma control remained suboptimal, prompting further investigation into potential causes.

During the physical examination, the patient appeared fatigued and exhibited mild respiratory distress, with a respiratory rate of 24 breaths per minute. Auscultation revealed diffuse wheezing throughout all lung fields. Her oxygen saturation was slightly reduced at 92% on room air. Given these findings, the healthcare team suspected that there might be an additional contributing factor to her uncontrolled symptoms. A repeat CBC revealed a further increase in eosinophil count, and her serum IgE levels remained elevated, indicating that the inflammatory process was still active.

The persistence of symptoms despite optimized therapy and adherence to medication raised concerns about potential underlying factors, such as poor medication technique, non-compliance, or unidentified environmental triggers. The healthcare team considered the possibility of aspirin-exacerbated respiratory disease (AERD) or other comorbid conditions that could be influencing her asthma control. To address these concerns, they decided to initiate a more comprehensive asthma action plan, including detailed patient education on inhaler technique, and planned for a referral to an allergist for further evaluation. These efforts aimed to identify all possible exacerbating factors and achieve better control of her asthma, preventing further complications in her respiratory health.

Section 3

Following the decision to enhance the patient's asthma management plan, the healthcare team focused on refining her inhaler technique and identifying any environmental factors contributing to her ongoing symptoms. During a detailed assessment, the patient demonstrated improper use of her inhaler, failing to coordinate inhalation with actuation, which likely compromised the effectiveness of her medication. With guidance, she practiced the correct technique, including the use of a spacer to optimize drug delivery. Meanwhile, a thorough environmental history revealed a recent increase in exposure to a neighbor's cigarette smoke and the use of scented candles at home, both potential asthma triggers. The patient was advised to avoid these irritants, and educational materials were provided to reinforce the importance of environmental control.

Despite these interventions, the patient's condition did not significantly improve, prompting the allergist to conduct further diagnostic testing. A methacholine challenge test confirmed bronchial hyperreactivity, and a detailed allergy panel identified specific sensitivities to dust mites and mold. These new findings suggested that her asthma was exacerbated by both allergic and non-allergic triggers, complicating her management. To address this multi-faceted issue, the allergist recommended initiating allergen immunotherapy and increasing her inhaled corticosteroid dosage to better control inflammation.

As the patient began allergen immunotherapy and adhered to her updated medication regimen, her symptoms gradually started to stabilize. Her peak flow readings showed less variability, and her nocturnal symptoms were reduced. However, she experienced an episode of acute sinusitis, likely related to underlying allergic rhinitis, which temporarily worsened her asthma symptoms. The healthcare team promptly treated the sinusitis with appropriate antibiotics and nasal corticosteroids. This response highlighted the interconnected nature of her respiratory conditions, underscoring the importance of managing comorbidities to maintain asthma control. The patient's case exemplifies the complexity of asthma management, requiring ongoing clinical reasoning and adaptation of her treatment plan to address evolving complications.

Section 4

As the patient continued her allergen immunotherapy and updated medication regimen, her asthma symptoms initially showed marked improvement. However, during a routine follow-up, she reported experiencing increased shortness of breath and chest tightness over the past several days, particularly in the early morning hours despite adhering to her treatment plan. A physical examination revealed mild expiratory wheezing and her peak flow readings had decreased by 15% from her personal best, suggesting a decline in her asthma control.

In response to these changes in her condition, the healthcare team conducted additional diagnostic tests to better understand the underlying causes of her symptoms. A comprehensive spirometry test indicated a reduction in FEV1 (Forced Expiratory Volume in one second) by 20%, confirming reversible airway obstruction. Additionally, a repeat blood test showed elevated eosinophil counts, which suggested persistent inflammation possibly linked to her allergic responses.

Given these findings, the healthcare team decided to adjust her treatment strategy once again. The patient's inhaled corticosteroid dosage was further increased, and a leukotriene receptor antagonist was added to her regimen to better manage the inflammatory component of her asthma. She was also referred to a respiratory therapist for ongoing education and support. This new approach aimed to provide a more comprehensive management of her condition, considering both her allergic and non-allergic triggers, and emphasized the need for continuous monitoring and adaptation of her asthma management plan. The team recognized that managing her asthma would likely continue to require a dynamic and multifaceted approach, taking into account her individual response to treatment and any new complications that might arise.

Section 5

In the weeks following the adjustment to her treatment plan, the patient initially reported a slight improvement in her symptoms, experiencing reduced shortness of breath and chest tightness. However, during a subsequent visit to the clinic, she described a new set of symptoms that had recently emerged. She complained of persistent fatigue, intermittent headaches, and an unusual sensation of facial pressure, particularly around her eyes and cheeks. These symptoms were more pronounced in the mornings and seemed to fluctuate with changes in her environment, such as exposure to cold air or during periods of increased pollen count.

Upon conducting a thorough physical examination, the healthcare team noted mild edema and tenderness in the maxillary sinuses, suggestive of a developing sinusitis. Her vital signs were stable with a respiratory rate of 18 breaths per minute, oxygen saturation at 96% on room air, and a slightly elevated heart rate at 92 beats per minute. Although her lung examination revealed persistent mild wheezing, the presence of sinus-related symptoms indicated a possible complication of her asthma, potentially exacerbated by her underlying allergies.

To further investigate, the team ordered a CT scan of the sinuses, which confirmed acute sinusitis, likely contributing to her overall respiratory discomfort. As a result, her treatment plan was again revised to include a short course of oral antibiotics to address the sinus infection, alongside the continuation of her asthma management regimen. The healthcare team emphasized the importance of addressing both respiratory and sinus components to optimize her asthma control and prevent further exacerbation. This development highlighted the interconnected nature of her condition, necessitating an integrated approach that considered both respiratory and sinus health in her ongoing care.